Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis. Bader JM, Makarov C, Richter S, Strauss MT, et al. Cell 2026;189:2128-2147.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bader JM, Makarov C, Richter S, Strauss MT, et al. Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis. Cell 2026;189:2128-2147.
PMID: 41747728